Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ninghan Zhang
Observed name:
ZHANG Ninghan
Institutions:
Jiangsu Province Hospital,
Nanjing Medical University
Observed institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College,
Jiangsu Province Hospital,
Nanjing Medical University
OpenAlex ID:
A5058535070
Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia
2019
·
Jialei Qi
, Xiang Gao
, et al.
·
Biomedicine & Pharmacotherapy
·
24
PDF
MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
2018
·
Chen Yang
, Tingting Shao
, et al.
·
Journal of Translational Medicine
·
19
PDF
High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
2019
·
Huihui Zhang
, Ninghan Zhang
, et al.
·
Journal of Translational Medicine
·
18
PDF
MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation
2020
·
Rong Wang
, Huihui Zhang
, et al.
·
Frontiers in Oncology
·
13
PDF
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
2019
·
Mingshan Niu
, Yuan Feng
, et al.
·
Cancer Cell International
·
13
PDF
High expression of miR‐338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy
2019
·
Lin Fu
, Jialei Qi
, et al.
·
Journal of Cellular Physiology
·
12
CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia
2021
·
Ninghan Zhang
, Jiawen Xu
, et al.
·
Journal of Molecular Medicine
·
7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia
2024
·
Xiao Chen
, Xia Chen
, et al.
·
Cytometry Part B Clinical Cytometry
·
4
PDF
MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia
2019
·
Mingshan Niu
, Ninghan Zhang
, et al.
·
Frontiers in Oncology
·
4
PDF
CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia From Marginal Zone Lymphoma
2025
·
Zhen Guo
, Jing Su
, et al.
·
Modern Pathology
·
2
CARMA1 Is Required for Notch1-Induced NF-κb Activation in T-Cell Acute Lymphoblastic Leukemia
2019
·
Rong Wang
, Ninghan Zhang
, et al.
·
Blood
·
1
CD49d promotes T‐cell senescence in chronic lymphocytic leukaemia
2025
·
Min Wang
, Zhen Guo
, et al.
·
British Journal of Haematology
Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemia
2022
·
Xiao Chen
, Sishu Zhao
, et al.
·
Research Square
PDF
MiR-340 Expression As a Prognostic Marker to Guide Clinical Decision-Making in Acute Myeloid Leukemia
2019
·
Tingting Shao
, Yuan Feng
, et al.
·
Blood
Show more works
View as search
Works count:
15
Citation count:
117
H-index:
7
I10-index:
6
Year
Topic
Type